Posted on

Financial Toxicity Prevalent In Older Cancer Patients.

Posted on

About one in five older cancer patients report experiencing financial toxicity, according to researchers from the University of Rochester in New York.

In a large cohort of more than 500 patients aged 70 years and older, 18% stated they were experiencing financial problems related to the cost of their treatment and that this was taking a toll on their care, quality of life, and mental well-being.

Compared with those not experiencing financial issues, patients reporting financial toxicity had a higher prevalence of severe anxiety (18% vs 7%) and depression (27% vs 21%), as well as a poorer quality of life (41% vs 22%).

The study also found that many older patients report delaying taking medication and/or are unable to afford their basic needs, explained lead author Asad Arastu, MSc, a medical student at the University of Rochester.

“Patients said that they were unable to afford medication and also had problems like the need to take time off work, not being able to afford gas, and cost concerns in other domains,” he told “There are a lot of missed opportunities, as patients have these concerns and they are not being discussed.”

The findings will be presented at the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2018. The study is a secondary analysis of baseline data from a geriatric assessment intervention study that was conducted across 31 practice sites.

Well-Established “Side Effect” of Cancer Therapy

Financial toxicity has become a well-established “side effect” of cancer care, with many patients experiencing varying levels of distress related to the cost of their care.

However, financial toxicity is a subjective measure without a standard definition, Arastu commented. In order to measure the impact of financial toxicity on cancer patients in their study, the team developed an easy-to-use screening measure for cancer patients based on the current literature.

Patients were categorized as experiencing financial toxicity if they answered yes to any of three questions:

  • Have you ever delayed medications because of cost?
  • Have you ever had insufficient income in a typical month for food or housing?
  • Have you ever had insufficient income in a typical month for other basic needs?

“The three questions are practical and easy for oncologists to use,” said Arastu, noting that measurement and assessment tools can often be cumbersome and time consuming for both the patient and physician to fill out.

Senior author Supriya Gupta Mohile, MD, the Wehrheim professor of medicine at the Wilmot Cancer Institute, University of Rochester Medical Center, agrees and said the study has changed her own practice.

-GDMeds, an India Pharmacy Service company

[Disclaimer]The Site is operated by GDMeds and all rights thereto are owned and reserved by GDMeds. The contents and works on these pages compiled by GDMeds are subject to copyright law. Copying, processing, distribution and any kind of use outside the limits of copyright law require the written consent of GDMeds In case the content is not created by GDMeds the copyrights of third parties are being observed. However, if a user becomes aware of a copyright infringement, GDMeds asks the user for notification. Upon notification of such violations, GDMeds will remove the content immediately.


[отказ]Сайт управляется GDMeds, и все права на него принадлежат и зарезервированы GDMeds. Содержание и работы на этих страницах, составленные GDMeds, защищены законом об авторском праве. Копирование, обработка, распространение и любое использование вне пределов авторского права требуют письменного согласия GDMeds. Если контент не создан GDMeds, то соблюдаются авторские права третьих лиц. Однако, если пользователь узнает о нарушении авторских прав, GDMeds запрашивает у пользователя уведомление. После уведомления о таких нарушениях GDMeds немедленно удалит контент.